118 related articles for article (PubMed ID: 29380334)
1. Mass Spectrometry Profiling of Pituitary Glands.
Krishnamurthy D; Rahmoune H; Guest PC
Methods Mol Biol; 2018; 1735():439-447. PubMed ID: 29380334
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Profiling of the Pituitary Gland in Studies of Psychiatric Disorders.
Krishnamurthy D; Rahmoune H; Guest PC
Adv Exp Med Biol; 2017; 974():313-319. PubMed ID: 28353251
[TBL] [Abstract][Full Text] [Related]
3. Liquid Chromatography Tandem Mass Spectrometry Analysis of Proteins Associated with Age-Related Disorders in Human Pituitary Tissue.
Guest PC; Martins-de-Souza D
Methods Mol Biol; 2020; 2138():263-276. PubMed ID: 32219755
[TBL] [Abstract][Full Text] [Related]
4. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the human pituitary proteome by data independent label-free liquid chromatography tandem mass spectrometry.
Krishnamurthy D; Levin Y; Harris LW; Umrania Y; Bahn S; Guest PC
Proteomics; 2011 Feb; 11(3):495-500. PubMed ID: 21268279
[TBL] [Abstract][Full Text] [Related]
6. Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification.
High AA; Tan H; Pagala VR; Niu M; Cho JH; Wang X; Bai B; Peng J
J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286450
[TBL] [Abstract][Full Text] [Related]
7. Large-Scale and Deep Quantitative Proteome Profiling Using Isobaric Labeling Coupled with Two-Dimensional LC-MS/MS.
Gritsenko MA; Xu Z; Liu T; Smith RD
Methods Mol Biol; 2016; 1410():237-47. PubMed ID: 26867748
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of the human pituitary tissue: bioanalytical methods and applications.
Giorgianni F; Koirala D; Beranova-Giorgianni S
Bioanalysis; 2014; 6(14):1989-2003. PubMed ID: 25158968
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Profiling of Protein Kinase Inhibitor Targets by Mass Spectrometry.
Golkowski M; Maly DJ; Ong SE
Methods Mol Biol; 2017; 1636():105-117. PubMed ID: 28730476
[TBL] [Abstract][Full Text] [Related]
10. Phosphoproteomic analysis of the human pituitary.
Beranova-Giorgianni S; Zhao Y; Desiderio DM; Giorgianni F
Pituitary; 2006; 9(2):109-20. PubMed ID: 16807684
[TBL] [Abstract][Full Text] [Related]
11. Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.
Smith J; Davey G; Polom K; Roviello F; Bones J
J Chromatogr A; 2018 Sep; 1566():32-43. PubMed ID: 29945787
[TBL] [Abstract][Full Text] [Related]
12. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
13. Shotgun proteomic analysis of microdissected postmortem human pituitary using complementary two-dimensional liquid chromatography coupled with tandem mass spectrometer.
Liu Y; Zhuang D; Hou R; Li J; Xu G; Song T; Chen L; Yan G; Pang Q; Zhu J
Anal Chim Acta; 2011 Mar; 688(2):183-90. PubMed ID: 21334484
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Analysis of the Human Anterior Pituitary Gland.
Yelamanchi SD; Tyagi A; Mohanty V; Dutta P; Korbonits M; Chavan S; Advani J; Madugundu AK; Dey G; Datta KK; Rajyalakshmi M; Sahasrabuddhe NA; Chaturvedi A; Kumar A; Das AA; Ghosh D; Jogdand GM; Nair HH; Saini K; Panchal M; Sarvaiya MA; Mohanraj SS; Sengupta N; Saxena P; Subramani PA; Kumar P; Akkali R; Reshma SV; Santhosh RS; Rastogi S; Kumar S; Ghosh SK; Irlapati VK; Srinivasan A; Radotra BD; Mathur PP; Wong GW; Satishchandra P; Chatterjee A; Gowda H; Bhansali A; Pandey A; Shankar SK; Mahadevan A; Prasad TSK
OMICS; 2018 Dec; 22(12):759-769. PubMed ID: 30571610
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
16. Proteome research based on modern liquid chromatography--tandem mass spectrometry: separation, identification and quantification.
Fröhlich T; Arnold GJ
J Neural Transm (Vienna); 2006 Aug; 113(8):973-94. PubMed ID: 16835695
[TBL] [Abstract][Full Text] [Related]
17. Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry.
Kota U; Chien KY; Goshe MB
Methods Mol Biol; 2009; 564():303-21. PubMed ID: 19544030
[TBL] [Abstract][Full Text] [Related]
18. An off-line high pH reversed-phase fractionation and nano-liquid chromatography-mass spectrometry method for global proteomic profiling of cell lines.
Wang H; Sun S; Zhang Y; Chen S; Liu P; Liu B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():90-5. PubMed ID: 25463202
[TBL] [Abstract][Full Text] [Related]
19. Identification of plasma biomarkers for diffuse axonal injury in rats by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Zhang P; Zhu S; Zhao M; Zhao P; Zhao H; Deng J; Li J
Brain Res Bull; 2018 Sep; 142():224-232. PubMed ID: 30077728
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
